On May 21, 2025, RAPT Therapeutics, Inc. received notice from Nasdaq that its stock price fell below the minimum requirement of $1.00 for continued listing, with a compliance deadline of November 17, 2025. The company is considering a reverse stock s
AI Assistant
RAPT THERAPEUTICS INC
2025
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.